Clinical Trial Update: Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects [Phase 4]

View source ↗

Summary

Phase 4 trial update on empagliflozin assessing cardiovascular, renal, and metabolic effects in heart failure and diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Heart Failure, Diabetes Mellitus | Phase 4 | Status: COMPLETED